GHK-Cu Peptide Support Plan

This treatment plan outlines the dosage, administration, expected benefits, and potential side effects of GHK-Cu (copper peptide). Please read this plan carefully, along with the information provided with your medication, for complete details regarding precautions, handling, and other important safety information.

GHK-Cu therapy is considered supportive and investigational in nature and is typically used as part of a broader wellness or regenerative plan.

For regenerative support, you have been prescribed:

GHK-Cu (10 mg/mL, 5 mL vial,  50 mg total)

Dosing:

• Inject 200 mcg daily
• 25 doses total (25-day course)

General guidance:

• Administer via subcutaneous injection (under the skin) unless otherwise directed
• Use a new sterile needle and syringe for each injection
• Rotate injection sites (commonly abdomen or thigh)
• Do not exceed the prescribed dose
• Store medication as directed (commonly refrigerated after opening)
• Do not use if the solution appears discolored or contains particles

GHK-Cu works at the cellular level and does not produce immediate or symptomatic effects. Benefits may develop gradually over time with consistent use.

Use only as prescribed. Do not increase your dose or frequency without provider guidance.

GHK-Cu is considered investigational and is not FDA-approved for the treatment of specific medical conditions.

Possible side effects may include mild injection site irritation, redness, or discomfort.

Systemic side effects are not well characterized due to limited large-scale clinical data.

If you experience unusual symptoms, discontinue use and contact your provider.

Do not use this medication if the vial has been compromised or improperly stored.

For your safety, do not share this medication or use it outside of medical supervision.

This medication contains the following active ingredient. Do not use if you are allergic to this ingredient or any components provided with the medication.

• GHK-Cu (Copper Peptide)

Allergic reactions are uncommon but possible.

Stop this medication and seek medical care if you experience:

• Rash or hives
• Swelling of the face, lips, or throat
• Difficulty breathing
• Severe injection site reaction

We evaluate your health history based on the information you provide. If any of the following apply or develop during treatment, discontinue use and seek in-person evaluation:

• Known hypersensitivity to peptide therapies
• Active infection at injection site
• Unexplained systemic symptoms
• Pregnancy or breastfeeding (safety not established)
• Significant underlying medical conditions without provider clearance

We evaluate the specific health information you provide and make our recommendations based on it. If you incorrectly provide that information, we may misdiagnose or fail to diagnose conditions that you may have which could affect our recommendation for treatment.

We recommend this treatment because the potential benefits of treatment outweigh the risks. You should evaluate this information as well as the manufacturer’s pamphlet, and any input from your in-person healthcare team, or other information to decide if this treatment plan is appropriate for you. You are free to decline our treatment recommendations although, doing so may prolong symptoms and be associated with negative outcomes.

We have based our recommendation on your specific case and medical guidelines, but there may be alternative treatments or strategies that may be helpful to you. Some may be more or less effective than what we provide. Some treatments may require an in-person exam or procedure which we can’t provide.

You can access your records anytime. We strongly recommend that you update your in-person doctor, pharmacist, and the rest of your healthcare team to let them know about any new medicines you are taking or other changes in your health.